SPRO ALERT: Klein Law Firm

NEW YORK, July 5, 2022 /PRNewswire/ — Klein Law Firm Announces Class Action Lawsuit Has Been Filed on Behalf of Spero Therapeutics, Inc. (NASDAQ: SPRO) Shareholders Alleging the Company Violated Federal Securities Laws .

Class period: October 28, 2021 at May 2, 2022
Lead Applicant Deadline: July 25, 2022
No obligation or cost to you.

Learn more about your recoverable losses in SPRO:

Spero Therapeutics, Inc. NEWS – SPRO NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Spero Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) data submitted in support of the New Drug Application (“NDA”) for the Company’s product candidate, Tebipenem HBr, were insufficient to obtain U.S. Food and Drug Administration (“FDA”) approval; (ii) as a result, it was unlikely that the FDA would approve the NDA Tebipenem HBr in its current form; (iii) the foregoing would require significant downsizing and restructuring of Spero’s business; and (iv) as a result, the Company’s public statements were materially false and misleading at all material times.

WHAT THIS MEANS FOR YOU AS A SHAREHOLDER: If you have suffered a claim in Spero, you have until July 25, 2022 ask the court to obtain the status of principal plaintiff. Your ability to participate in any collection does not require you to serve as the lead plaintiff.

AT NO CHARGE TO YOU: If you purchased Spero securities during the relevant period, you may be entitled to compensation without payment of any disbursements.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For more information on the SPRO trial, please contact J. Klein, Esq. by phone at 212-616-4899 or click on this link: https://www.kleinstocklaw.com/pslra-1/spero-therapeutics-inc-loss-submission-form?id=29465&from=4.


J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud across the country. Klein Law Firm is a litigation firm with experience in a wide range of areas, including securities law, corporate finance and commercial litigation. Since 2011, our experienced lawyers have achieved superior results for our clients with a personalized approach. Lawyer advertisement. Prior results do not guarantee similar results.

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899

View original content: https://www.prnewswire.com/news-releases/spro-alert-the-klein-law-firm-announces-a-lead-plaintiff-deadline-of-july-25-2022-in – the-class-action-filed-on-behalf-of-spero-therapeutics-inc-shareholders-301579917.html

SOURCE Klein Law Firm